173 related articles for article (PubMed ID: 9408323)
1. Impaired T cell functions preceding lymphoproliferative disorders in mice neonatally tolerized to transplantation antigens.
Jánossy T; Vizler C; Ocsovszki I; Tibbe GJ; Pipis J; Savelkoul HF; Végh P; Benner R
Acta Chir Hung; 1997; 36(1-4):150-1. PubMed ID: 9408323
[TBL] [Abstract][Full Text] [Related]
2. Autoimmunity, hyporeactivity to T cell mitogens and lymphoproliferative disorders following neonatal induction of transplantation tolerance in mice.
Jánossy T; Baranyi L; Knulst AC; Vizler C; Benner R; Kelényi G; Végh P
Eur J Immunol; 1993 Nov; 23(11):3011-20. PubMed ID: 8223878
[TBL] [Abstract][Full Text] [Related]
3. Host-versus-graft disease in mice after the induction of neonatal transplantation tolerance by two different methods.
Pipis J; Jánossy T; Modok S; Ocsovszki I; Hidvégi Z; Horváth G; Végh P; Benner R
Acta Chir Hung; 1997; 36(1-4):280-1. PubMed ID: 9408374
[TBL] [Abstract][Full Text] [Related]
4. Adoptive transfer of unresponsiveness to allogeneic skin grafts with hepatic gamma delta + T cells.
Gorczynski RM
Immunology; 1994 Jan; 81(1):27-35. PubMed ID: 8132216
[TBL] [Abstract][Full Text] [Related]
5. Characterization of donor chimerism, alloreactive host T cells and memory cell development in thymi from mice resistant to neonatal transplantation tolerance.
Ruiz P; Nassiri M; Viciana AL; Padmanabhan J; Streilein JW
J Immunol; 1995 Jan; 154(2):633-43. PubMed ID: 7814872
[TBL] [Abstract][Full Text] [Related]
6. Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease.
Drobyski WR; Majewski D; Hanson G
Biol Blood Marrow Transplant; 1999; 5(4):222-30. PubMed ID: 10465102
[TBL] [Abstract][Full Text] [Related]
7. Ex vivo anti-CD3 antibody-activated donor T cells have a reduced ability to cause lethal murine graft-versus-host disease but retain their ability to facilitate alloengraftment.
Drobyski WR; Majewski D; Ozker K; Hanson G
J Immunol; 1998 Sep; 161(5):2610-9. PubMed ID: 9725263
[TBL] [Abstract][Full Text] [Related]
8. Induction of neonatal transplantation tolerance and lymphoproliferative disorders in mice: the role of F1 donor cells.
Jánossy T; Baranyi L; Vizler C; Nyirati I; Végh P
Transplant Proc; 1995 Feb; 27(1):188-90. PubMed ID: 7878968
[No Abstract] [Full Text] [Related]
9. Unconventional NK1.1(-) intermediate TCR cells as major T lymphocytes expanding in chronic graft-versus-host disease.
Miyakawa R; Miyaji C; Watanabe H; Yokoyama H; Tsukada C; Asakura H; Abo T
Eur J Immunol; 2002 Sep; 32(9):2521-31. PubMed ID: 12207336
[TBL] [Abstract][Full Text] [Related]
10. Regional oral tolerance in transgenic 2C mice.
Margenthaler JA; Flye MW
Surgery; 2005 Aug; 138(2):141-9. PubMed ID: 16153420
[TBL] [Abstract][Full Text] [Related]
11. Early regulation of CD8 T cell alloreactivity by CD4+CD25- T cells in recipients of anti-CD154 antibody and allogeneic BMT is followed by rapid peripheral deletion of donor-reactive CD8+ T cells, precluding a role for sustained regulation.
Fehr T; Takeuchi Y; Kurtz J; Wekerle T; Sykes M
Eur J Immunol; 2005 Sep; 35(9):2679-90. PubMed ID: 16082727
[TBL] [Abstract][Full Text] [Related]
12. Changes in expression of T-cell activation-related molecules and cytokines during tolerance induction in an allogeneic skin transplantation murine model.
Lee EN; Kim EY; Lee J; Lee HJ; Lee KW; Joh JW; Lee SK; Lee DS; Lee HH; Kim SJ
Transplant Proc; 2004 Oct; 36(8):2425-8. PubMed ID: 15561268
[TBL] [Abstract][Full Text] [Related]
13. Prevention of graft-versus-host disease by a novel immunosuppressant, (5R)-5-hydroxytriptolide (LLDT-8), through expansion of regulatory T cells.
Tang W; Yang Y; Zhang F; Li YC; Zhou R; Wang JX; Zhu YN; Li XY; Yang YF; Zuo JP
Int Immunopharmacol; 2005 Dec; 5(13-14):1904-13. PubMed ID: 16275625
[TBL] [Abstract][Full Text] [Related]
14. A CD8 DE loop peptide analog prevents graft-versus-host disease in a multiple minor histocompatibility antigen-mismatched bone marrow transplantation model.
Choksi S; Kim JC; Whitaker-Menezes D; Murphy GF; Friedman TM; Korngold R
Biol Blood Marrow Transplant; 2004 Oct; 10(10):669-80. PubMed ID: 15389433
[TBL] [Abstract][Full Text] [Related]
15. Early loss of precursors of CTL and IL 2-producing cells in the development of neonatal tolerance to alloantigens.
Carnaud C; Ishizaka ST; Stutman O
J Immunol; 1984 Jul; 133(1):45-51. PubMed ID: 6233373
[TBL] [Abstract][Full Text] [Related]
16. Specific donor Vbeta-associated CD4 T-cell responses correlate with severe acute graft-versus-host disease directed to multiple minor histocompatibility antigens.
Jones SC; Friedman TM; Murphy GF; Korngold R
Biol Blood Marrow Transplant; 2004 Feb; 10(2):91-105. PubMed ID: 14750075
[TBL] [Abstract][Full Text] [Related]
17. CTLA4-CD80/CD86 interactions on primary mouse CD4+ T cells integrate signal-strength information to modulate activation with Concanavalin A.
Mukherjee S; Ahmed A; Nandi D
J Leukoc Biol; 2005 Jul; 78(1):144-57. PubMed ID: 15788440
[TBL] [Abstract][Full Text] [Related]
18. The immunologic function of 1B2+ double negative (CD4-CD8-) T cells in the 2C transgenic mouse.
Margenthaler JA; Flye MW
J Surg Res; 2005 Jun; 126(2):160-6. PubMed ID: 15919414
[TBL] [Abstract][Full Text] [Related]
19. T cell proliferative responses to a mitogen derived from Mycoplasma arthritidis are controlled by the accessory cell.
Lynch DH; Gurish MF; Cole BC; Daynes RA
J Immunol; 1983 Oct; 131(4):1702-6. PubMed ID: 6413576
[TBL] [Abstract][Full Text] [Related]
20. Type 2 immune deviation has differential effects on alloreactive CD4+ and CD8+ T cells.
Matesic D; Valujskikh A; Pearlman E; Higgins AW; Gilliam AC; Heeger PS
J Immunol; 1998 Nov; 161(10):5236-44. PubMed ID: 9820495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
